Drug General Information
Drug ID
D03IKZ
Former ID
DIB000970
Drug Name
HBP-347
Synonyms
HBP-347 (oral, cancer/autoimmunity/ocular disease); Hypericin (oral, cancer/autoimmunity/ocular disease), Hy BioPharma; HBP-347 (oral, cancer/autoimmunity/ocular disease), Hy BioPharma; Hypericin (oral, cancer/autoimmunity/ocular disease), Weizmann Institute/New York University; HBP-347 (oral, cancer/autoimmunity/ocular disease), Weizmann Institute/New York University
Indication Autoimmune diabetes [ICD10:E08-E13] Discontinued in Phase 3 [550048]
Company
Weizmann Institute of Science
Target and Pathway
Target(s) Heat shock protein HSP90 Target Info Modulator [550909]
References
Ref 550048Heat shock protein 90 (Hsp90). SciBX 4(18).
Ref 550909US patent application no. 2013,0023,420, Susceptibility to hsp90-inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.